用光动力学疗法增强抗血管内皮生长因子,治疗多性胆道血管病变:一个元分析
Ting-Han Lin1, Hung-Yi Lin2, Po-Chen Tseng3
1China Medical University Hospital, China Medical University, Taichung, Taiwan.
Survey of ophthalmology
|December 21, 2024
概括
与光动力学疗法 (PDT) 和抗血管内皮生长因子 (anti-VEGF) 药物的联合治疗对于多性胆道血管病变 (PCV) 比抗VEGF单一治疗更有效,减少了所需的注射.
科学领域:
- 眼科医生 眼科 眼科
- 医学研究 医学研究
- 临床试验 临床试验
背景情况:
- 聚性冠状血管病变 (PCV) 通常用抗血管内皮生长因子 (anti-VEGF) 药物治疗,或与白素光动力学疗法 (PDT) 进行组合治疗.
- 现有的随机对照试验 (RCT) 有局限性,包括小样本大小和不一致的预后数据,导致持续的治疗争议.
研究的目的:
- 系统地评估和比较PDT加抗VEGF联合治疗与抗VEGF单一治疗治疗PCV的疗效.
- 为PCV的第一线治疗提供基于证据的建议.
主要方法:
- 一个系统的审查和对7个随机对照试验 (RCT) 的元分析,涉及926只眼睛,坚持PRISMA声明.
- 在PubMed,Embase和Cochrane数据库中搜索到2024年7月之前发表的研究.
- 分析了关于全息肉回归,抗VEGF注射次数,视力敏度,视网膜中心厚度和眼部不良事件的数据.
主要成果:
- 组合疗法显示了完全多回归的显著更高率 (RR:1.56,p=0.005).
- 在组合治疗中,需要的抗VEGF注射较少 (SMD: -0.65,p<0.0001).
- 两种治疗方式都显示了最佳校正视敏度,中枢视网膜厚度减少和眼部不良事件的可比结果.
结论:
- 光动力疗法加上抗VEGF组合疗法是PCV的安全有效治疗方法.
- 这种组合治疗应被认为是PCV患者首选的第一线治疗选择.
关键词:
与年龄相关的斑点退化症抗血管内皮生长因子的抗血管内皮生长因子综合模式治疗疗法 综合模式治疗光动力学疗法 光动力学疗法聚合性冠状血管病变 (Polypoidal Choroidal Vasculopathy) 是一种多重的疾病.更多相关视频
11:04An In-House-Built and Light-Emitting-Diode-Based Photodynamic Therapy Device for Enhancing Verteporfin Cytotoxicity in a 2D Cell Culture Model
Published on: January 13, 2023
3.0K
05:14Author Spotlight: Overcoming Anti-VEGF Resistance Through Advanced Vascular Morphology Assessment in Choroidal Neovascularization
Published on: August 11, 2023
1.0K
相关概念视频
Mechanism of Angiogenesis
Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
Regulation of Angiogenesis and Blood Supply
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Vascular Spasm
The vascular phase, also known as vasospasm, is the initial stage of hemostasis, crucial for preventing excessive bleeding when a blood vessel is injured. After a vessel is cut, nerves in the damaged area trigger pain and other sensory impulses. Simultaneously, the smooth muscles in the vessel wall contract, resulting in a vascular spasm. This contraction reduces the vessel's diameter at the injury site, slowing or stopping blood loss through the vessel wall. Vascular spasms typically last for...
Autoregulation of Blood Flow
Autoregulation mechanisms are characterized by their inherent capacity for self-regulation without necessitating specific nervous stimulation or endocrine control. These mechanisms facilitate the adjustment of blood flow and, therefore, perfusion specific to each tissue region. This self-regulation encompasses chemical signals and myogenic controls.
Chemical Signaling in Autoregulation
Chemical signaling operates at the precapillary sphincter level, inciting either contraction or relaxation.
Chemical Signaling in Autoregulation
Chemical signaling operates at the precapillary sphincter level, inciting either contraction or relaxation.
